Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab ; volume:14 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.1.2024), 1-7, 12.2024
- Creator
-
Dallari, Simone
Martinez Pazos, Vicky
Munoz Eusse, Juan
Wellens, Judith
Thompson, Craig
Colombel, Jean-Frederic
Satsangi, Jack
Cadwell, Ken
Wong, Serre-Yu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-50035-1
- URN
-
urn:nbn:de:101:1-2024031508410628600683
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dallari, Simone
- Martinez Pazos, Vicky
- Munoz Eusse, Juan
- Wellens, Judith
- Thompson, Craig
- Colombel, Jean-Frederic
- Satsangi, Jack
- Cadwell, Ken
- Wong, Serre-Yu
- SpringerLink (Online service)
Other Objects (12)
The Convalescent
The convalescent
The illustrious convalescent
Establishing a many-cytokine signature via multivariate anomaly detection
"The convalescent" in France
The Liverpool convalescent institution.
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome
Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel disease
Urinary calcium excretion in short bowel syndrome patients receiving cyclic parenteral nutrition: Case report
The Convalescent
The convalescent
The illustrious convalescent
Establishing a many-cytokine signature via multivariate anomaly detection
"The convalescent" in France
The Liverpool convalescent institution.
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome
Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel disease
Urinary calcium excretion in short bowel syndrome patients receiving cyclic parenteral nutrition: Case report
The Convalescent
The convalescent
The illustrious convalescent
Establishing a many-cytokine signature via multivariate anomaly detection
"The convalescent" in France
The Liverpool convalescent institution.
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome
Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel disease